Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1211685.RAcU_N250rJi7hpQ-DdW1zpGhZFejg512QuNuQ4zWw0mY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1211685.RAcU_N250rJi7hpQ-DdW1zpGhZFejg512QuNuQ4zWw0mY130_assertion type Assertion NP1211685.RAcU_N250rJi7hpQ-DdW1zpGhZFejg512QuNuQ4zWw0mY130_head.
- NP1211685.RAcU_N250rJi7hpQ-DdW1zpGhZFejg512QuNuQ4zWw0mY130_assertion description "[Moreover, inhibitors of PI3K/mTOR and GLI signaling reduced neuroblastoma cell growth, but no additional growth inhibitory effects were detected when the two classes of drugs were combined.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1211685.RAcU_N250rJi7hpQ-DdW1zpGhZFejg512QuNuQ4zWw0mY130_provenance.
- NP1211685.RAcU_N250rJi7hpQ-DdW1zpGhZFejg512QuNuQ4zWw0mY130_assertion evidence source_evidence_literature NP1211685.RAcU_N250rJi7hpQ-DdW1zpGhZFejg512QuNuQ4zWw0mY130_provenance.
- NP1211685.RAcU_N250rJi7hpQ-DdW1zpGhZFejg512QuNuQ4zWw0mY130_assertion SIO_000772 25134527 NP1211685.RAcU_N250rJi7hpQ-DdW1zpGhZFejg512QuNuQ4zWw0mY130_provenance.
- NP1211685.RAcU_N250rJi7hpQ-DdW1zpGhZFejg512QuNuQ4zWw0mY130_assertion wasDerivedFrom befree-2016 NP1211685.RAcU_N250rJi7hpQ-DdW1zpGhZFejg512QuNuQ4zWw0mY130_provenance.
- NP1211685.RAcU_N250rJi7hpQ-DdW1zpGhZFejg512QuNuQ4zWw0mY130_assertion wasGeneratedBy ECO_0000203 NP1211685.RAcU_N250rJi7hpQ-DdW1zpGhZFejg512QuNuQ4zWw0mY130_provenance.